HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Evdoxia Rapti Selected Research
Evdoxia Rapti Research Topics
Disease
2
COVID-19
01/2022 - 11/2020
2
Critical Illness (Critically Ill)
11/2020 - 03/2010
1
Thrombotic Microangiopathies
01/2021
1
Infections
11/2020
1
Pulmonary Arterial Hypertension
09/2020
1
Hemorrhage
12/2018
1
Atrial Fibrillation
12/2018
1
Septic Shock (Toxic Shock Syndrome)
03/2010
1
Sepsis (Septicemia)
03/2010
1
Thrombophilia
03/2010
1
Essential Thrombocythemia
01/2008
1
Thrombocytosis (Thrombocythemia)
01/2008
1
Venous Thrombosis (Deep-Vein Thrombosis)
06/2007
1
Venous Thromboembolism
06/2007
Drug/Important Bio-Agent (IBA)
3
Hemostatics (Antihemorrhagics)
IBA
11/2020 - 03/2010
3
Plasminogen Activators (Plasminogen Activator)
IBA
11/2020 - 06/2007
2
Complement System Proteins (Complement)
IBA
01/2022 - 01/2021
2
Anticoagulants
IBA
11/2020 - 12/2018
2
Thrombin
FDA Link
11/2020 - 12/2018
1
antineoplaston A10 (A 10)
IBA
11/2020
1
Rivaroxaban
IBA
12/2018
1
apixaban
IBA
12/2018
1
Steroids
IBA
03/2010
1
factor V Leiden
IBA
03/2010
1
Fibrinogen (Factor I)
FDA Link
03/2010
1
A-factor (Streptomyces)
IBA
03/2010
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2008
Therapy/Procedure
1
Therapeutics
11/2020